David Nicholson

David Nicholson

Direttore/Membro del Consiglio presso ACTINIUM PHARMACEUTICALS, INC.

Patrimonio netto: 373 $ in data 30/09/2026

72 anni
Health Technology
Commercial Services
Finance

Profilo

Dr. David C.
Nicholson
is a Chairman at Exscientia AI Ltd., an Operational Partner at Gilde Healthcare Partners, Inc., a Lead Independent Director at Actinium Pharmaceuticals, Inc. and a Non-Executive Chairman at Wild Bioscience Ltd. He is on the Board of Directors at Tarus Therapeutics, Inc., Science Exchange, Inc., Actinium Pharmaceuticals, Inc., Rapalogix Health, Inc. and Volastra Therapeutics, Inc. Dr. Nicholson was previously employed as an Independent Director by Adverum Biotechnologies, Inc., a Non-Executive Chairman by Exscientia Ltd., a Vice Chairman by Transcelerate Biopharma, Inc., an Executive VP, Chief Research & Development Officer by Allergan Ltd. (Ireland), a Senior Vice President by Forest Laboratories, Inc., a Chief Technology Officer & Executive VP by Bayer CropScience AG, a CTO, Head-Research & Development by Bayer Crop Science Solutions LLC, a Vice President-Licensing & Knowledge Management by Merck & Co., Inc., a SVP-Global Project Management & Drug Safety by Schering-Plough Corp.
USA, an Executive Vice President-Research & Development by Organon Biosciences, Inc., and an Executive Vice President-Research & Development by Organon International, Inc. He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.
He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Wales.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
02/10/2026 333 ( 0% ) 373 $ 30/09/2026

Posizioni attive di David Nicholson

SocietàPosizioneInizio
ACTINIUM PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 01/01/2008
Direttore/Membro del Consiglio 28/06/2018
Investitore di Private Equity 01/09/2020
Direttore/Membro del Consiglio -
Presidente 03/11/2023
Presidente 01/10/2020
Direttore/Membro del Consiglio 14/05/2020

Precedenti posizioni note di David Nicholson

SocietàPosizioneFine
ADVERUM BIOTECHNOLOGIES, INC. Direttore/Membro del Consiglio 09/12/2025
EXSCIENTIA PLC Presidente 12/02/2024
░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di David Nicholson

Formazione di David Nicholson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

81

Relazioni di 1° grado

22

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Mercati
  2. Insiders
  3. David Nicholson